HomeIMRX • NASDAQ
add
Immuneering Corp
Previous close
$1.29
Day range
$1.29 - $1.53
Year range
$1.00 - $3.83
Market cap
51.62M USD
Avg Volume
184.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.48M | 1.04% |
Net income | -15.05M | -5.16% |
Net profit margin | — | — |
Earnings per share | -0.42 | 14.29% |
EBITDA | -15.39M | -1.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 35.87M | -49.68% |
Total assets | 50.68M | -42.40% |
Total liabilities | 8.84M | -4.55% |
Total equity | 41.84M | — |
Shares outstanding | 35.99M | — |
Price to book | 1.11 | — |
Return on assets | -74.88% | — |
Return on capital | -84.64% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.05M | -5.16% |
Cash from operations | -14.08M | 9.11% |
Cash from investing | -8.94K | -100.04% |
Cash from financing | 13.81M | 1,309.35% |
Net change in cash | -279.02K | -104.05% |
Free cash flow | -9.21M | 11.97% |
About
Founded
2008
Website
Employees
54
